Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences - Quaterly Results

>>

Zydus Lifesciences - Quaterly Results

>>

Zydus Lifesciences informs about post results conference call

>>

Zydus Lifesciences zooms on launching Bemdac to treat uncontrolled LDL-c

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences launches Bemdac to treat uncontrolled LDL-c

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences’ arm gets tentative approval from USFDA for Selexipag Tablets

>>

Zydus Lifesciences gets approval from USFDA for Bortezomib for Injection

>>

Zydus Lifesciences’ ZyCoV-D gets emergency use authorisation from DCGI as two dose vaccine

<< < 65 66 67 ...168 > >>